AOM INT'L (00381) announced its interim results for the six months ended June 30, 2025. The group achieved revenue of HK$203 million, representing a 41.71% increase compared to the same period last year. However, the company recorded a loss attributable to owners of HK$6.013 million, compared to a profit of HK$17.613 million in the corresponding period of the previous year. The loss per share was HK$0.76 cents.

The decrease in profit attributable to equity holders during this period was primarily due to the group's share of losses from investments in associates, no gains recorded from the elimination of financial liabilities through share issuance in 2025, and reduced segment profit from Chinese herbal medicines.